Pineridge Advisors’s National Healthcare NHC Stock Holding History

Pineridge Advisors’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,000	Closed	-$2.68M	–	757
2023 Q4	$2.68M	Buy	+29,000	New	+$2.22M	0.89%	18

Other funds holding NHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pineridge Advisors's NHC Position: Q1 2024 in Review

Pineridge Advisors sold out of National Healthcare (NHC) in Q1 2024, closing a stake of 29,000 shares — an estimated $2.68M sold.

Pineridge Advisors first reported a position in NHC in Q4 2023 and held it in 1 quarter. The position peaked at $2.68M in Q4 2023. 170 funds tracked by Wall St. Rank hold NHC as of Q1 2024.

Pineridge Advisors reported no remaining National Healthcare position as of Q1 2024 after selling out during the quarter.
Pineridge Advisors sold 29,000 National Healthcare shares in Q1 2024, an estimated $2.68M.
Pineridge Advisors first reported a position in National Healthcare in Q4 2023 and held it in 1 quarter.
Pineridge Advisors's National Healthcare position peaked at $2.68M in Q4 2023.
170 funds tracked by Wall St. Rank held National Healthcare as of Q1 2024.

Based on Pineridge Advisors's 13F filing for Q1 2024, filed 16 May 2024.